Literature DB >> 3399831

Evidence for weakening of gastric mucus integrity by Campylobacter pylori.

J Sarosiek1, A Slomiany, B L Slomiany.   

Abstract

The role of Campylobacter pylori in weakening the mucus component of the gastric mucosal barrier was investigated. The extracellular material elaborated by C. pylori, cultured from antral mucosal biopsy specimens of patients undergoing gastroscopy, caused a rapid degradation of mucus glycoprotein polymer to glycopeptides comparable in size to those produced by the action of pepsin. Viscosity measurements showed that incubation of C. pylori filtrate with gastric mucus led to a gradual loss in mucus viscosity, which at the end of 48 h decreased by 36%. The C. pylori filtrate also had a detrimental effect on the ability of mucus to retard the diffusion of H+. After 12 h of incubation the permeability of mucus to H+ increased by 10%, whereas a 32% increase in permeability was observed after 48 h. The results suggest that the degenerative changes produced in gastric mucus gel by C. pylori may be a contributing factor in the pathogenesis of gastritis and peptic ulcer.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3399831     DOI: 10.3109/00365528809093916

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  31 in total

Review 1.  Immunopathology of Helicobacter pylori infection and disease.

Authors:  S J Czinn; J G Nedrud
Journal:  Springer Semin Immunopathol       Date:  1997

2.  The prevalence of Campylobacter pylori gastritis among asymptomatic adults.

Authors:  D B Gregson; D E Low; M M Cohen; N B Cooter; J J Connon; S L Wolman; A E Simor
Journal:  CMAJ       Date:  1989-06-15       Impact factor: 8.262

3.  Restorative impact of rabeprazole on gastric mucus and mucin production impairment during naproxen administration: its potential clinical significance.

Authors:  T Jaworski; I Sarosiek; S Sostarich; K Roeser; M Connor; S Brotze; G Wallner; J Sarosiek
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

4.  Significant enhancement of gastric mucin content after rabeprazole administration: its potential clinical significance in acid-related disorders.

Authors:  T Skoczylas; I Sarosiek; S Sostarich; C McElhinney; S Durham; J Sarosiek
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

5.  Cloning and characterization of hemolytic genes from Helicobacter pylori.

Authors:  E S Drazek; A Dubois; R K Holmes; D Kersulyte; N S Akopyants; D E Berg; R L Warren
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

6.  Helicobacter pylori in vivo causes structural changes in the adherent gastric mucus layer but barrier thickness is not compromised.

Authors:  J L Newton; N Jordan; L Oliver; V Strugala; J Pearson; O F James; A Allen
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

7.  Partial characterization of an external polysaccharide of Helicobacter pylori by using an immunoglobulin M monoclonal antibody.

Authors:  E B Drouet; H P De Montclos; M Andujar; M Boude; J A Grimaud; G A Denoyel
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

8.  Helicobacter pylori infection does not reduce the viscosity of human gastric mucus gel.

Authors:  D C Markesich; B S Anand; G M Lew; D Y Graham
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

9.  Neutrophil activation by Helicobacter pylori.

Authors:  C Mooney; J Keenan; D Munster; I Wilson; R Allardyce; P Bagshaw; B Chapman; V Chadwick
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

10.  Intestinal mucus entrapment of Trichinella spiralis larvae induced by specific antibodies.

Authors:  M S Carlisle; D D McGregor; J A Appleton
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.